02 October 2025
EssilorLuxottica has completed its acquisition of Optegra from MidEuropa.
The provider of ophthalmology services operates more than 70 eye hospitals and diagnostic facilities in five European markets: the UK, Czech Republic, Poland, Slovakia, and the Netherlands.
In a statement, EssilorLuxottica suggested the acquisition of Optegra was a “natural fit” for its med-tech portfolio, representing a milestone in the group’s strategy to “enhance eye health solutions and improve access to the most personalised and seamless patient journey.”
The statement confirmed that the transaction has been cleared by relevant competition authorities.
On the announcement of the acquisition plans in May, Dr Peter Byloos, chief executive officer of Optegra Eye Health Care, commented: “This partnership not only accelerates our growth potential but also enhances our ability to deliver advanced, digital and integrated eye care solutions to all our patients.”
At EssilorLuxottica, Francesco Milleri, chairman and chief executive officer, and Paul du Saillant, deputy chief executive officer, suggested that Optegra’s clinical professionals would bring “new medical capabilities” to the group “enabling us to address patients’ needs with the most advanced vision care technologies and treatments in one trusted system that will anchor our med-tech aspirations.”
“Powered by our growing AI and big data capabilities, we will be able to broaden our impact and deliver the most personalised and seamless patient journey,” the leaders said.
Comments (0)
You must be logged in to join the discussion. Log in